Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations.

Boulanger, J; Boursiquot, J N; Cournoyer, G; Lemieux, J; Masse, M S; Almanric, K; Guay, M P

Boulanger, J; Boursiquot, J N; Cournoyer, G; Lemieux, J; Masse, M S; Almanric, K; Guay, M P.

Afiliação

Boulanger J; Institut national d'excellence en santé et services sociaux ( inesss ), Quebec City, QC.
Boursiquot JN; Centre hospitalier de l'Université Laval ( chu de Québec), Quebec City, QC.
Cournoyer G; Hôpital régional de Saint-Jérôme ( csss de Saint-Jérôme), Saint-Jérôme, QC.
Lemieux J; Hôpital du Saint-Sacrement ( chu de Québec), Quebec City, QC.
Masse MS; Hôpital Notre-Dame ( chum ), Montreal, QC.
Almanric K; Hôpital de la Cité-de-la-Santé ( csss de Laval), Laval, QC.
Guay MP; Jewish General Hospital, Montreal, QC.

Curr Oncol ; 21(4): e630-41, 2014 Aug.

Article em En | MEDLINE | ID: mdl-25089112

Palavras-chave

Hypersensitivity reactions; chemotherapy; desensitization; management; platinum salts; skin testing; taxanes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Curr Oncol Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google